Cite
HARVARD Citation
Salloway, S. et al. (2017). Performance of [18F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA‐AA recommendations for the neuropathologic diagnosis of Alzheimer's disease. Alzheimer's & dementia. 9 (1), pp. 25-34. [Online].